20170406 Telix Logo.png
Japanese Prostate Cancer Imaging Trial Meets Study Objectives
February 07, 2022 18:08 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) in collaboration with Kanazawa University today announces that...
arvinas_logoART_lg.jpg
Arvinas to Present at Upcoming Investor Conferences
February 03, 2022 16:30 ET | Arvinas Inc.
NEW HAVEN, Conn., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...
Global Oncology Precision Medicine Market
The Worldwide Oncology Precision Medicine Industry is Expected to Reach $64+ Billion by 2027
February 02, 2022 05:13 ET | Research and Markets
Dublin, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The "Worldwide Oncology Precision Medicine Industry" report has been added to ResearchAndMarkets.com's offering. This report provides a detailed analysis...
20170406 Telix Logo.png
First Patient Dosed in ProstACT Program for Prostate Cancer Therapy
January 26, 2022 16:51 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in the Company’s...
Curium to become maj
Curium to become major player in the supply on non carrier added Lu-177
January 25, 2022 00:00 ET | Curium
London, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Today Curium has announced a technology license agreement granting access to ECZACIBAŞI MONROL NÜKLEER ÜRÜNLER SANAYİ VE TİCARET A.Ş non carrier added...
Picture1.jpg
Curium to become major player in the supply on non carrier added Lu-177
January 25, 2022 00:00 ET | Curium
LONDON, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Today Curium has announced a technology license agreement granting access to ECZACIBAŞI MONROL NÜKLEER ÜRÜNLER SANAYİ VE TİCARET A.Ş non carrier added...
22157.jpg
Global Community Oncology Services Markets Analysis & Forecasts, 2015-2020, 2020-2025F, 2030F
January 10, 2022 04:23 ET | Research and Markets
Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Community Oncology Services Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. ...
20170406 Telix Logo.png
FDA Approves Telix’s Prostate Cancer Imaging Product, Illuccix®
December 19, 2021 16:47 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company), a global biopharmaceutical company focused on the development...
20170406 Telix Logo.png
Telix and NUCLIBER Sign Distribution Agreement for Prostate Cancer Imaging in Spain
December 07, 2021 17:42 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and MADRID, Spain, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive...
22157.jpg
Global Interventional Oncology Devices Market, 2021-2030: Opportunities in the Emergence of Local Companies in Asia-Pacific and the Middle East and Africa
December 06, 2021 06:43 ET | Research and Markets
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Market Analysis and Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering. The global...